PhaseBio Pharmaceuticals, Inc.

Focused on discovery and development of therapeutic fusion proteins based on its proprietary Elastin-Like Polypeptide (ELP) technology

Sector: Biopharmaceuticals, Healthcare
Company Status: Private
Investment Status: Current